- Report
- May 2024
- 369 Pages
Global
From €5381EUR$5,600USD£4,627GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- November 2023
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- April 2024
- 135 Pages
Global
From €3746EUR$3,899USD£3,221GBP
- Report
- October 2023
- 150 Pages
Global
From €4660EUR$4,850USD£4,007GBP
- Report
- October 2023
- 172 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- October 2023
- 178 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- October 2023
- 178 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- September 2023
- 190 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- October 2023
- 156 Pages
Global
From €2402EUR$2,500USD£2,066GBP
- Report
- August 2023
- 175 Pages
Global
From €3060EUR$3,185USD£2,631GBP
€4372EUR$4,550USD£3,759GBP
- Report
- February 2024
- 110 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- February 2024
- 110 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- January 2024
- 140 Pages
Global
From €4324EUR$4,500USD£3,718GBP
- Report
- January 2024
- 148 Pages
Global
From €4324EUR$4,500USD£3,718GBP
- Report
- March 2024
- 200 Pages
Global
From €3988EUR$4,150USD£3,429GBP
- Report
- January 2024
- 200 Pages
Global
From €3988EUR$4,150USD£3,429GBP
- Report
- December 2023
- 250 Pages
Global
€4799EUR$4,995USD£4,127GBP
The Embryonic Stem Cell (ESC) market is a subset of the larger stem cell market. ESCs are derived from embryos and are pluripotent, meaning they can differentiate into any cell type in the body. They are used in research to study the development of cells and tissues, and in regenerative medicine to replace damaged or diseased cells. ESCs are also used in drug discovery and development, as they can be used to test the safety and efficacy of new drugs.
The ESC market is highly regulated, as the use of embryos is controversial. Regulations vary by country, and some countries have banned the use of ESCs altogether. Despite this, the ESC market is growing, driven by advances in stem cell research and the potential for regenerative medicine.
Companies in the ESC market include Cellular Dynamics International, Pluristem Therapeutics, and Stem Cell Therapeutics. These companies are involved in the research, development, and commercialization of ESCs for therapeutic and research applications. Show Less Read more